Is Aurora Spine Corporation (ASG.V) a Buy, Sell, or Hold?
TSXV : ASG.V
Aurora Spine Corporation
$0.25 CAD
$0.01 (2.04%)
- Volume
- 3.5K
- Average Volume
- 41.24K
- Market Capitalization
- $19.52M
- P/E Ratio
- -23.48
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.36
- Year Low
- $0.21
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.53
Industry, Sector & symbol
| Stock Exchange | TSXV |
| CEO | Trent J. Northcutt |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Current Symbol | ASG.V |
| CUSIP | 05206X108 |
| CIK | None |
| Web | https://www.aurora-spine.com |
| Phone | 760-424-2004 |
| Currency | CAD |
| Employees | 13 |
| Country | CA |
Liquidity
| Debt-to-Equity Ratio | 0.62 |
| Payout Ratio | 0.00 |
| Current Ratio | 2.53 |
| Quick Ratio | 1.41 |
| Cash Ratio | 0.27 |
Sales & Book Value
| Annual Sales | $18.37M |
| Price / Sales | 0.76 |
| Cash Flow | 0.01 |
| Price / Cash Flow | 18.24 |
| Price / Book | 3.84 |
Price Target and Rating
| Average Stock Price Forecast | |
| High Stock Price Forecast | |
| Low Stock Price Forecast | |
| Forecast Upside/Downside | % |
| Consensus Rating | Strong Sell |
| Rating Score(0-5) | 1 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | -$0.0095 |
| Trailing P/E Ratio | -23.48 |
| PEG Ratio | -1.38 |
| P/E Growth | -1.38 |
| Net Income | -$743.92K |
| Net Margin | -3.24% |
| Pretax Margin | -3.17% |
| Return on Equity | -15.61% |
| Return on Assets | -6.11% |
Financials Score
| AltmanZ Score | -0.26 |
| Piotroski Score | 5.00 |
| Working Capital | 4.41M |
| Total Assets | 9.72M |
| Ebit | -192.84K |
| Market Cap | 13.91M |
| Total Liabilities | 6.09M |
Poll Results
About Aurora Spine Corporation (TSXV:ASG.V) Stock
Established in 2013 and headquartered in Toronto, Canada, Aurora Spine Corporation, through its subsidiary Aurora Spine, Inc., specializes in the development and distribution of advanced, minimally invasive spinal fusion systems and devices within the Canadian market. The company offers a comprehensive portfolio of products designed to address various spinal conditions, particularly degenerative disc diseases. This includes interspinous process lumbar fusion devices such as the ZIP series (ZIP, ZIP ULTRA, ZIP LP, and ZIP-51). Aurora Spine also provides Ti-Coated polyether ether ketone (PEEK) interbody cages, which are crucial for maintaining space and stability between vertebrae while facilitating bone fusion. Its offerings extend to sterile-packed titanium plasma spray coated spinal fusio ... n implants that promote bone growth. Key interbody products comprise EOS, VOX, Echo, Echo SD, and EchoXL for the lumbar region, and Discovery for cervical applications. The company also manufactures SOLO, an anterior lumbar interbody fusion (ALIF) 3D-printed stand-alone device featuring an integrated plate and spacer system for anatomical preservation and spinal support. For sacroiliac joint issues, Aurora Spine provides SiLo, a posterior fusion device. Furthermore, the DEXA-C cervical interbody system, a porous 3D-printed intervertebral body fusion device with customizable lattice density options, is available to match patient bone quality.
Aurora Spine Grants Stock Options
2026-06-09 18:07:00
Carlsbad, California--(Newsfile Corp. - June 9, 2026) - Aurora Spine Corporation (TSXV: ASG) (OTCQB: ASAPF) ("Aurora Spine" or the "Company"), a leader
Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2026 Financial Results
2026-05-26 17:16:14
CARLSBAD, Calif. , May 26, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, today announced it will file its financial results with SEDAR for its first quarter of fiscal year 2026 for the period ended March 31, 2026, on Wednesday, May 27, 2026, after market hours.
2026-05-07 07:15:00
CARLSBAD, Calif. , May 07, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, today announced the issuance of its fourth U. S. patent related to Aurora's proprietary DEXA Technology platform.
Frequently Asked Questions
-
What is the current Aurora Spine Corporation (ASG.V) stock price?
-
Aurora Spine Corporation(TSXV:ASG.V) stock price is $0.25 in the last trading session. During the trading session, ASG.V stock reached the peak price of $0.355 while $0.205 was the lowest point it dropped to. The percentage change in ASG.V stock occurred in the recent session was 2.04% while the dollar amount for the price change in ASG.V stock was $0.01.
-
ASG.V's industry and sector of operation?
-
The TSXV listed ASG.V is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of ASG.V?
-
Matt Paxton | Executive Vice President of Sales
Matthew Goldstone | Chief Commercial Officer
Chad Clouse | Chief Financial Officer
Laszlo Garamszegi | Chief Technology Officer & Founder
Trent J. Northcutt | Founder, President, Chief Executive Officer & Director -
How many employees does ASG.V have?
-
Number of ASG.V employees currently stands at 13. ASG.V operates from 20 Holly Street, Toronto, ON M4S 3B1, CA.
-
Link for ASG.V official website?
-
Official Website of ASG.V is: https://www.aurora-spine.com
-
How do I contact ASG.V?
-
ASG.V could be contacted at phone #760-424-2004 and can also be accessed through its website. ASG.V operates from 20 Holly Street, Toronto, ON M4S 3B1, CA.
-
How many shares of ASG.V are traded daily?
-
The average number of ASG.V shares traded daily for last 3 months was 41.24K.
-
What is the market cap of ASG.V currently?
-
The market value of ASG.V currently stands at $19.52M with its latest stock price at $0.25